These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15774425)

  • 1. Clinical management of spasticity.
    Thompson AJ; Jarrett L; Lockley L; Marsden J; Stevenson VL
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):459-63. PubMed ID: 15774425
    [No Abstract]   [Full Text] [Related]  

  • 2. Immediate versus delayed electrical stimulation boosts botulinum toxin effect: A pilot study.
    Picelli A; Smania N; Storti I; Munari D; Fontana C; Fiaschi A; Santilli V; Tamburin S
    Mov Disord; 2011 Aug; 26(9):1784-5. PubMed ID: 21538521
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment and treatment of movement disorders in children with cerebral palsy.
    Deon LL; Gaebler-Spira D
    Orthop Clin North Am; 2010 Oct; 41(4):507-17. PubMed ID: 20868881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral palsy: the whys and hows.
    Fairhurst C
    Arch Dis Child Educ Pract Ed; 2012 Aug; 97(4):122-31. PubMed ID: 22868578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
    Balbaloglu O; Basaran A; Ayoglu H
    J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of cerebral palsy: What we know, what we don't know.
    Goldstein M
    J Pediatr; 2004 Aug; 145(2 Suppl):S42-6. PubMed ID: 15292887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
    Barrett RS
    Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical management of spasticity.
    Helsel P; McGee J; Graveline C
    J Child Neurol; 2001 Jan; 16(1):24-30. PubMed ID: 11225953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin, physical and occupational therapy, and neuromuscular electrical stimulation to treat spastic upper limb of children with cerebral palsy: a pilot study.
    Rodríguez-Reyes G; Alessi-Montero A; Díaz-Martínez L; Miranda-Duarte A; Pérez-Sanpablo AI
    Artif Organs; 2010 Mar; 34(3):230-4. PubMed ID: 20447049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The authors respond.
    Van Campenhout A; Bar-On L
    Arch Phys Med Rehabil; 2015 Apr; 96(4):760-1. PubMed ID: 25616393
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
    Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
    Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
    [No Abstract]   [Full Text] [Related]  

  • 14. [Botulinum toxin A and physical therapy in gait in cerebral palsy].
    García-Sánchez SF; Gómez-Galindo MT; Guzmán-Pantoja JE
    Rev Med Inst Mex Seguro Soc; 2017; 55(1):18-24. PubMed ID: 28092243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botox in combined treatment of cerebral palsy in children].
    Kalinina LV; Sologubov EG; Luzinovich VM; Dutikova EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):60-3. PubMed ID: 11195541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of botulinum toxin in pediatric spasticity (cerebral palsy).
    Berweck S; Heinen F
    Mov Disord; 2004 Mar; 19 Suppl 8():S162-7. PubMed ID: 15027070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
    Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of permanent cerebellar stimulation on senso-motor disorders in cerebral palsy (author's transl)].
    Winkelmüller W; Seidel BU; Dietz H
    Neurochirurgia (Stuttg); 1977 Nov; 20(6):179-85. PubMed ID: 304185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.
    Naidu K; Smith K; Sheedy M; Adair B; Yu X; Graham HK
    Dev Med Child Neurol; 2010 Feb; 52(2):139-44. PubMed ID: 20412252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.